Citadel Advisors’s Progyny PGNY Stock Holding History
Bought
Maintained
Sold
Other funds holding PGNY
VPM
VCM
FWIA
SCM
Citadel Advisors's PGNY Position: Q1 2026 in Review
Citadel Advisors sold out of Progyny (PGNY) in Q1 2026, closing a stake of 2,160,796 shares — an estimated $46.3M sold.
Citadel Advisors first reported a position in PGNY in Q4 2019 and held it in 25 quarters. The position peaked at $78M in Q3 2023. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.
- Citadel Advisors reported no remaining Progyny position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 2,160,796 Progyny shares in Q1 2026, an estimated $46.3M.
- Citadel Advisors first reported a position in Progyny in Q4 2019 and held it in 25 quarters.
- Citadel Advisors's Progyny position peaked at $78M in Q3 2023.
- 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.